APA (7th ed.) Citation

Alraddadi, S. I., Almodaimegh, H., Kharbosh, A., Alharbi, H., Fathelrahman, A. I., Alsheikh, M. Y., & Alfehaid, L. (2025). Evolocumab safety and efficacy in hypercholesteremia patients with or without diabetes: A retrospective real-world analysis. Diabetology & Metabolic Syndrome, 17(1), 1. https://doi.org/10.1186/s13098-025-01587-x

Chicago Style (17th ed.) Citation

Alraddadi, Sultan Ibrahim, Hind Almodaimegh, Abdullah Kharbosh, Hadeel Alharbi, Ahmed Ibrahim Fathelrahman, Mona Yaser Alsheikh, and Lama Alfehaid. "Evolocumab Safety and Efficacy in Hypercholesteremia Patients with or Without Diabetes: A Retrospective Real-world Analysis." Diabetology & Metabolic Syndrome 17, no. 1 (2025): 1. https://doi.org/10.1186/s13098-025-01587-x.

MLA (9th ed.) Citation

Alraddadi, Sultan Ibrahim, et al. "Evolocumab Safety and Efficacy in Hypercholesteremia Patients with or Without Diabetes: A Retrospective Real-world Analysis." Diabetology & Metabolic Syndrome, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13098-025-01587-x.